Survival and response rates according to histology in matched populations
| . | TriNHL (n = 85) . | De novo LBCL (n = 85) . | P value . |
|---|---|---|---|
| Survival | |||
| PFS at 1 year (95% CI), % | 55.8 (43.6-66.4) | 31.7 (21.4-42.6) | .0029 |
| HR (95% CI) | 0.54 (0.36-0.82) | 1 (reference) | |
| OS at 1 year (95% CI), % | 72.1 (59.6-81.4) | 50.7 (38.2-62.0) | .0305 |
| HR (95% CI) | 0.59 (0.36-0.96) | 1 (reference) | |
| DOR at 1 year (95% CI), % | 62.1 (48.3-73.2) | 46.1 (31.8-59.3) | .0610 |
| HR (95% CI) | 0.60 (0.363-0.995) | 1 (reference) | |
| Response rate | |||
| ORR (95% CI), % | 82.4 (72.6-89.8) | 63.5 (52.4-73.7) | .010 |
| CRR (95% CI), % | 63.5 (52.4-73.7) | 50.6 (39.5-61.6) | .121 |
| . | TriNHL (n = 85) . | De novo LBCL (n = 85) . | P value . |
|---|---|---|---|
| Survival | |||
| PFS at 1 year (95% CI), % | 55.8 (43.6-66.4) | 31.7 (21.4-42.6) | .0029 |
| HR (95% CI) | 0.54 (0.36-0.82) | 1 (reference) | |
| OS at 1 year (95% CI), % | 72.1 (59.6-81.4) | 50.7 (38.2-62.0) | .0305 |
| HR (95% CI) | 0.59 (0.36-0.96) | 1 (reference) | |
| DOR at 1 year (95% CI), % | 62.1 (48.3-73.2) | 46.1 (31.8-59.3) | .0610 |
| HR (95% CI) | 0.60 (0.363-0.995) | 1 (reference) | |
| Response rate | |||
| ORR (95% CI), % | 82.4 (72.6-89.8) | 63.5 (52.4-73.7) | .010 |
| CRR (95% CI), % | 63.5 (52.4-73.7) | 50.6 (39.5-61.6) | .121 |